Freeline Therapeutics Holdings plc Annual Operating Income (Loss) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2022.
  • Freeline Therapeutics Holdings plc Operating Income (Loss) for the quarter ending March 31, 2023 was -$20.1M, a 28.7% increase year-over-year.
  • Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2022 was -$98.4M, a 30.9% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2021 was -$142M, a 39% decline from 2020.
  • Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2020 was -$102M, a 61% decline from 2019.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$98.4M +$43.9M +30.9% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 -$142M -$39.9M -39% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 -$102M -$38.8M -61% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
2019 -$63.6M -$22.7M -55.3% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 -$41M Jan 1, 2018 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.